Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Type of study
Language
Affiliation country
Publication year range
1.
J Med Case Rep ; 9: 85, 2015 Apr 19.
Article in English | MEDLINE | ID: mdl-25928714

ABSTRACT

INTRODUCTION: Combined pulmonary fibrosis and emphysema has recently been recognized as a syndrome but remains under-diagnosed. Neither clinical management nor therapeutic approaches have been clearly defined. Pulmonary rehabilitation has not been considered within the therapeutic options for combined pulmonary fibrosis and emphysema. In this case we explored the potential benefits of a specific aerobic physical retraining program in the management of combined pulmonary fibrosis and emphysema. CASE PRESENTATION: We describe the case of a 65-year-old Caucasian man with combined pulmonary fibrosis and emphysema and respiratory failure who was receiving long-term oxygen therapy. Our patient underwent physical retraining with moderate intensity aerobic and breathing exercises for four weeks. Clinical and motor tests, as well as questionnaires assessing quality of life and depression levels, were performed prior to and following the retraining. At the end of the retraining program a relevant reduction of long-term oxygen therapy requirement was registered; improvements in terms of physical performance, quality of life, and mood were observed in our patient but no change in respiratory parameters. CONCLUSIONS: A program of aerobic physical retraining appears to be beneficial to patients with combined pulmonary fibrosis and emphysema and may be considered as an additional therapeutic option.


Subject(s)
Exercise Therapy , Pulmonary Emphysema/rehabilitation , Pulmonary Fibrosis/rehabilitation , Aged , Breathing Exercises/methods , Exercise/physiology , Humans , Male , Oxygen Inhalation Therapy/methods , Pulmonary Emphysema/etiology , Pulmonary Fibrosis/etiology , Syndrome , Nicotiana/adverse effects
2.
In Vivo ; 28(4): 557-61, 2014.
Article in English | MEDLINE | ID: mdl-24982222

ABSTRACT

In recent literature, little has been said regarding the morphological changes that occur in lung cells after treatment with particles and nanoparticles. Using an in vitro model of type-II lung epithelium (A549), we studied the effects of submicron particles (PM1.0), Parietaria officinalis (ALL), and PM1.0 + ALL together. To date several biochemical effects have been described, instead few data exist in literature regarding morphological events following these treatments, in particular we focused on the morphological changes and distribution of mitochondria, tonifilaments and rough endoplasmic reticulum, using a transmission electron microscopic (TEM) approach. After exposure to PM1.0 particles (PM1.0), Parietaria officinalis as allergen, and PM1.0 with P. officinalis, changes in the cytoplasmic area were observed, such as damage to mitochondria and morphological alterations of the tonifilaments and rough endoplasmic reticulum. The data obtained strongly support the hypothesis that cells in contact with submicron particles (PM1.0), or P. officinalis, undergo alteration of their metabolism.


Subject(s)
Allergens/adverse effects , Epithelial Cells/drug effects , Epithelial Cells/pathology , Particulate Matter/toxicity , Pollen/adverse effects , Vehicle Emissions/toxicity , Allergens/toxicity , Cell Line, Tumor , Cells, Cultured , Endoplasmic Reticulum, Rough/ultrastructure , Epithelial Cells/ultrastructure , Humans , Mitochondria/ultrastructure , Pollen/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL